ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
CARsgen Therapeutics Presents Updated Multiple Myeloma Cell Therapy Data at the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition
December 07, 2020CARsgen Therapeutics announced updated safety and efficacy results from its ongoing global clinical studies of CT053, an investigational chimeric antigen receptor (CAR) T-cell therapy for patients with relapsed and/or refractory multiple myeloma (RRMM). -
Multiple myeloma treatment receives Orphan Drug Designation
September 03, 2019Orphan drug designation has been granted to the CT053 anti-BCMA CAR-T program for multiple myeloma treatment.
Pharma Sources Insight January 2025
